{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:46:19Z","timestamp":1759333579757},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,3,23]],"date-time":"2008-03-23T00:00:00Z","timestamp":1206230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s11239-008-0214-1","type":"journal-article","created":{"date-parts":[[2008,3,22]],"date-time":"2008-03-22T02:24:17Z","timestamp":1206152657000},"page":"31-34","source":"Crossref","is-referenced-by-count":22,"title":["Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity"],"prefix":"10.1007","volume":"26","author":[{"given":"Noha A.","family":"Irani-Hakime","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghid","family":"Kreidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Jureidini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,23]]},"reference":[{"key":"214_CR1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archderm.1975.01630140046003","volume":"111","author":"AL Schroeter","year":"1975","unstructured":"Schroeter AL, Diaz Perez JL, Winkelmann RK (1975) Livedo vasculitis (the vasculitis of atrophie blanche): immunohistopathologic study. Arch Dermatol 111:188\u2013193","journal-title":"Arch Dermatol"},{"key":"214_CR2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/00015550310015455","volume":"83","author":"AV Marzano","year":"2003","unstructured":"Marzano AV, Vanotti M, Alessi E (2003) Widespread livedoid vasculopathy. Acta Derm Venereol 83:457\u2013460","journal-title":"Acta Derm Venereol"},{"key":"214_CR3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archderm.1967.01610050011002","volume":"96","author":"JW Bard","year":"1967","unstructured":"Bard JW, Winkelmann RK (1967) Livedo vasculitis: segmental hyalinizing vasculitis of the dermis. Arch Dermatol 96:489\u2013499","journal-title":"Arch Dermatol"},{"key":"214_CR4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/archderm.134.4.491","volume":"134","author":"JL Jorizzo","year":"1998","unstructured":"Jorizzo JL (1998) Livedoid vasculopathy: what is it? Arch Dermatol 134:491\u2013493","journal-title":"Arch Dermatol"},{"key":"214_CR5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-2133.2003.05176.x","volume":"148","author":"D Mimouni","year":"2003","unstructured":"Mimouni D, Ng PP, Rencic A et\u00a0al (2003) Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol 148:789\u2013794","journal-title":"Br J Dermatol"},{"key":"214_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-4362.1999.00581.x","volume":"38","author":"MB Maessen-Visch","year":"1999","unstructured":"Maessen-Visch MB, Koedam MI, Hamuly\u00e1k K, Neumann HA (1999) Atrophie blanche. Int J Dermatol 38:161\u2013172","journal-title":"Int J Dermatol"},{"key":"214_CR7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archderm.142.11.1413","volume":"142","author":"BR Hairston","year":"2006","unstructured":"Hairston BR, Davis MD, Pittelkow MR, Ahmed I (2006) Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 142:1413\u20131418","journal-title":"Arch Dermatol"},{"key":"214_CR8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1034\/j.1600-0560.2000.027008410.x","volume":"27","author":"T Biedermann","year":"2000","unstructured":"Biedermann T, Flaig MJ, Sander CA (2000) Livedoid vasculopathy in a patient with factor V mutation (Leiden). J Cutan Pathol 27:410\u2013412","journal-title":"J Cutan Pathol"},{"key":"214_CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1067\/mjd.2002.117718","volume":"46","author":"KT Calamia","year":"2002","unstructured":"Calamia KT, Balabanova M, Perniciaro C, Walsh JS (2002) Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol 46:133\u2013137","journal-title":"J Am Acad Dermatol"},{"key":"214_CR10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1440-0960.2007.00350.x","volume":"48","author":"NS Anavekar","year":"2007","unstructured":"Anavekar NS, Kelly R (2007) Heterozygous prothrombin gene mutation associated with livedoid vasculopathy. Australas J Dermatol 48:120\u2013123","journal-title":"Australas J Dermatol"},{"key":"214_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0190-9622(99)70207-0","volume":"40","author":"GE Gibson","year":"1999","unstructured":"Gibson GE, Li H, Pittelkow MR (1999) Homocysteinemia and livedoid vasculitis. J Am Acad Dermatol 40:279\u2013281","journal-title":"J Am Acad Dermatol"},{"key":"214_CR12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-4632.2007.03229.x","volume":"46","author":"R Cardoso","year":"2007","unstructured":"Cardoso R, Goncalo M, Tellechea O et\u00a0al (2007) Livedoid vasculopathy and hypercoagulability in a patient with primary Sjogren\u2019s syndrome. Int J Dermatol 46:431\u2013434","journal-title":"Int J Dermatol"},{"key":"214_CR13","first-page":"1466","volume":"142","author":"A Deng","year":"2006","unstructured":"Deng A, Gocke CD, Hess J et\u00a0al (2006) Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G\/4G) treated successfully with tissue plasminogen activator. Arch Dermatol 142:1466\u20131469","journal-title":"Arch Dermatol"},{"key":"214_CR14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1046\/j.1365-2133.2000.03786.x","volume":"143","author":"A Boyvat","year":"2000","unstructured":"Boyvat A, Kundak\u00e7i N, Babikir MO, G\u00fcrgey E (2000) Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol 143:840\u2013842","journal-title":"Br J Dermatol"},{"key":"214_CR15","first-page":"159","volume":"16","author":"F Meiss","year":"2006","unstructured":"Meiss F, Marsch WC, Fischer M (2006) Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. Eur J Dermatol 16:159\u2013162","journal-title":"Eur J Dermatol"},{"key":"214_CR16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2133.1999.02622.x","volume":"140","author":"KM Acland","year":"1999","unstructured":"Acland KM, Darvay A, Wakelin SH, Russell-Jones R (1999) Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol 140:131\u2013135","journal-title":"Br J Dermatol"},{"key":"214_CR17","first-page":"408","volume":"151","author":"A Grasland","year":"2000","unstructured":"Grasland A, Crickx B, Blanc M, Pouchot J, Vinceneux P (2000) Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies. Ann Med Interne (Paris) 151:408\u2013410","journal-title":"Ann Med Interne (Paris)"},{"key":"214_CR18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archderm.134.4.447","volume":"134","author":"M Papi","year":"1998","unstructured":"Papi M, Didona B, De Pita O et\u00a0al (1998) Livedo vasculopathy vs. small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. Arch Dermatol 134:447\u2013452","journal-title":"Arch Dermatol"},{"key":"214_CR19","first-page":"75","volume":"142","author":"CE Browning","year":"2006","unstructured":"Browning CE, Callen JP (2006) Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol 142:75\u201378","journal-title":"Arch Dermatol"},{"key":"214_CR20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00105-004-0709-4","volume":"55","author":"V Lewerenz","year":"2004","unstructured":"Lewerenz V, Burchardt T, B\u00fcchau A, Ruzicka T, Megahed M (2004) Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome. Hautarzt 55:379\u2013381","journal-title":"Hautarzt"},{"key":"214_CR21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archderm.139.8.987","volume":"139","author":"BR Hairston","year":"2003","unstructured":"Hairston BR, Davis MD, Gibson LE, Drage LA (2003) Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch Dermatol 139:987\u2013990","journal-title":"Arch Dermatol"},{"key":"214_CR22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-6196(12)60922-7","volume":"67","author":"KL Klein","year":"1992","unstructured":"Klein KL, Pittelkow MR (1992) Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc 67:923\u2013933","journal-title":"Mayo Clin Proc"},{"key":"214_CR23","first-page":"374","volume":"85","author":"G Pitarch","year":"2005","unstructured":"Pitarch G, Rodriguez-Serna M, Torrijos A, Oliver V, Fortea JM (2005) Treatment of livedoid vasculopathy with short-cycle intravenous immunoglobulins. Acta Derm Venereol 85:374\u2013375","journal-title":"Acta Derm Venereol"},{"key":"214_CR24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0248-8663(02)00611-2","volume":"23","author":"N Magy","year":"2002","unstructured":"Magy N, Algros MP, Racadot E et\u00a0al (2002) Liveoid vasculopathy with combined thrombophilia: efficacy of iloprost. Rev Med Interne 23:554\u2013557","journal-title":"Rev Med Interne"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-008-0214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-008-0214-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-008-0214-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:01:38Z","timestamp":1559372498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-008-0214-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1007\/s11239-008-0214-1","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,23]]}}}